Healthcare organizations and providers are facing more pressures than ever, from regulatory strains to financial squeezes. Blockchain is one area that can act as a major time and cost saver for healthcare organizations, according to a recent report from JPMorgan Chase.

Allergan, a global pharmaceutical company based in Dublin, has issued a voluntary recall for Biocell textured breast implants and tissue expanders after the action was requested by the FDA. The implants have been linked with several health problems and complications, including a rare form of cancer and death.

CMS Administrator Seema Verma does not support expanding the government-sponsored healthcare programs she oversees to all Americans.

With Medicare for all on the lips of many Democratic presidential candidates and public support for universal healthcare coverage at its highest ever, concerns about healthcare usage under such a system have arisen. However, hospital use isn’t likely to rise under a Medicare-for-all plan, according to research published in the Annals of Internal Medicine.

Amazon is in a fight for patient health data after a pharmacy industry player worked to block the e-commerce giant’s online pharmacy business, PillPack, from accessing the information.

Civica Rx, the not-for-profit drug company startup created by hospital and healthcare organizations to reduce the impact of rising drug costs and shortages, has found another pharmaceutical partner to manufacture and supply 14 essential sterile injectable medications.

According to provisional data from the CDC, overdose deaths from opioid abuse in the U.S. likely fell in 2018, representing the first decline in roughly 30 years.

For people with diabetes, turning 26 is a cliff that can turn deadly. That’s because, at that age, young adults are kicked off their parents’ insurance plans and must find their own coverage and continue taking life-saving medication they simply cannot afford.